Document is current
Any future updates will be listed below
-
Authors
Roy, Nainika
Haq, Imdadul
Ngo, Jason C.
Bennett, David A.
Teich, Andrew F.
De Jager, Philip L.
Olah, Marta
Sher, Falak
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG070118)
- License Information
-
More Information
Article History
Received: 19 September 2024
Revised: 5 November 2024
Accepted: 15 November 2024
First Online: 27 November 2024
Declarations
:
: The authors declare no competing interests.
: The research was conducted in accordance with the guidelines of Institutional Review Board (IRB) of Columbia University New York under protocol AAAR4962. This study utilized induced pluripotent stem cell (iPSC)-derived microglia, hence no direct human participants were involved. Human iPSC lines C1-iPSC (Gibco, catalog A18945), C2-iPSC (ATCC, catalog no. ACS-1024), and CU-iPSC (Columbia Stem Cell Initiative core facility), were obtained in accordance with ethical guidelines for research.
: This manuscript does not contain data from individuals necessitating consent for publication.
